Community Outreach and Engagement

CCSG构成部分005--社区外联和参与 项目摘要/摘要 范德比尔特-英格拉姆癌症中心(VICC)位于癌症发病率最高和 美国的死亡率。作为NCI指定的唯一一家为成人和成人提供服务的综合癌症中心 田纳西州(田纳西州)的儿科人口，VICC涵盖了广泛的地理和人口统计 来自田纳西州、肯塔基州西部和阿拉巴马州北部的123个县的多样化集水区 其中90%的VICC癌症患者目前是被抽出的。123个县中的70个(57%)被归类为 农村，25%的集水区人口居住在那里。VICC社区外联和接洽(COE)、 在副主任Pamela Hull的领导下，博士(CO)与VICC研究项目相结合 以及减少集水区内外癌症负担和差距的行政举措。 COE利用与患者和社区利益相关者的关系，以双向方式获得意见 来自社区关于研究、癌症控制和护理的优先事项，并与VICC研究计划合作 和社区合作伙伴将这些优先计划带到社区。COE的具体目标是 1)评估和确定集水区与癌症有关的需求和机会的优先次序；2)通报和促进 应对已确定的癌症相关需求和社区驱动的优先事项的方案研究； 3)推动循证癌症预防、控制和护理工作的实施和推广。 通过COE确定的社区驱动的优先事项包括癌症预防倡议、改善获得 通过技术、整体治疗和支持提供护理，实施循证做法和政策， 推进发现和研究倡导。VICC从事基础、临床和人口科学研究 这解决了集水区的需求，并与这些社区驱动的优先事项保持一致。COE员工协作 与合作伙伴合作，通过各种协作性社区拓展来满足不断发展的社区确定的需求 活动。与合作伙伴和利益相关者合作，VICC社区知情研究和癌症 控制活动协同作用有助于增强健康和癌症知识社区的能力 集水区和更远的地方。这些努力的影响在范德比尔特改进的实践中已经很明显 大学医学中心(VUMC)及其附属网站，包括新提供的烟草筛查/咨询， 增强了患者导航，扩大了肺癌筛查的范围，并提高了对乳房的依从性， 结直肠癌和宫颈癌筛查指南、HPV疫苗接种和遗传癌筛查。搬家 今后，重点将放在研究研究收益增加的指标上；癌症的改善- 相关知识、态度和行为；扩大执行循证准则和 健康政策。VICC与社区合作伙伴一起，通过支持 癌症的系统方法，推进基础研究，将发现从替补席上转化为 全国和全球集水区的诊所、社区和人口。

CCSG COMPONENT 005 – COMMUNITY OUTREACH AND ENGAGEMENT PROJECT SUMMARY/ABSTRACT Vanderbilt-Ingram Cancer Center (VICC) is located in a region with some of the highest cancer incidence and mortality rates in the US. As the only NCI-designated Comprehensive Cancer Center serving both adult and pediatric populations in Tennessee (TN), VICC encompasses a geographically wide and demographically diverse catchment area of 123 counties across TN, western Kentucky (KY), and northern Alabama (AL) from which 90% of VICC cancer patients currently are drawn. Seventy of the 123 counties (57%) are classified as rural, in which 25% of the catchment area population lives. VICC Community Outreach and Engagement (COE), under the leadership of Associate Director Pamela Hull, PhD (CO), integrates with VICC Research Programs and administrative initiatives to reduce the cancer burden and disparities within the catchment area and beyond. In a bi-directional manner, leveraging relationships with patients and community stakeholders, COE obtains input from the community on priorities for research, cancer control and care and works with VICC research programs and community partners to bring those prioritized initiatives out to the community. The specific aims of COE are to: 1) Assess and prioritize cancer-related needs and opportunities in the catchment area; 2) Inform and facilitate programmatic research that is responsive to identified cancer-related needs and community-driven priorities; and 3) Promote the implementation and dissemination of evidence-based cancer prevention, control and care. Community-driven priorities identified through COE include cancer prevention initiatives, improved access to care through technology, holistic treatment and support, implementation of evidence-based practice and policy, advancing discoveries, and research advocacy. VICC conducts basic, clinical and population science research that addresses catchment area needs and aligns with these community-driven priorities. COE staff collaborate with partners to meet evolving community-identified needs through a variety of collaborative community outreach activities. Working together with partners and stakeholders, VICC community-informed research and cancer control activities synergistically contribute to empowering healthy and cancer literate communities in our catchment area and beyond. The impact of these efforts is already evident in improved practices at Vanderbilt University Medical Center (VUMC) and affiliated sites, including newly available tobacco screening/counseling, enhanced patient navigation, expanded reach of lung cancer screening and improved adherence to breast, colorectal and cervical cancer screening guidelines, HPV vaccination and inherited cancer screening. Moving forward, focus will be placed on metrics of increased accruals to research studies; improvements in cancer- related knowledge, attitudes and behavior; and expanded implementation of evidence-based guidelines and health policies. Together with community partners, VICC positively impacts the catchment area by enabling a systems approach to cancer, advancing fundamental research and translating discoveries from the bench to the clinic, community and population in the catchment area, nationally, and globally.